A New Lead Identification Strategy: Screening an sp3‐rich and Lead‐like Compound Library Composed of 7‐Azanorbornane Derivatives. (20th September 2019)
- Record Type:
- Journal Article
- Title:
- A New Lead Identification Strategy: Screening an sp3‐rich and Lead‐like Compound Library Composed of 7‐Azanorbornane Derivatives. (20th September 2019)
- Main Title:
- A New Lead Identification Strategy: Screening an sp3‐rich and Lead‐like Compound Library Composed of 7‐Azanorbornane Derivatives
- Authors:
- Karaki, Fumika
Umemoto, Sho
Ashizawa, Karin
Oki, Tomoya
Sato, Noriko
Ogino, Takumi
Ishibashi, Naoto
Someya, Ryoto
Miyano, Kanako
Hirayama, Shigeto
Uezono, Yasuhito
Fujii, Hideaki - Abstract:
- Abstract: Although the advantages of sp 3 ‐rich, sterically complicated molecules in drug development have been pointed out, modern screening libraries are filled with planar, sp 2 ‐rich components. Compounds that are sp 3 ‐rich are difficult to synthesize, and thus we aimed to invent an efficient method to construct sp 3 ‐rich libraries. By modifying sp 3 ‐rich 7‐azanorbornane scaffolds through click chemistry, we efficiently prepared a small set of compounds. These compounds were not only sp 3 ‐rich, but also had sufficient "lead‐like" properties in view of molecular weights and hydrophobicity. Screening assays of this library provided weak κ opioid receptor agonists and growth hormone secretagogue receptor agonists with high hit rates. These results indicate that the 7‐azanorbornane scaffold may be a "privileged structure" for lead identification in drug discovery. Abstract : Privileged structure for hits : Despite the significance of sp 3 ‐hybridized carbons in today's medicinal chemistry, modern screening libraries are lacking in sp 3 ‐rich components. Herein we propose a novel and efficient strategy to construct an sp 3 ‐rich library with "lead‐like" properties. By modifying the sp 3 ‐rich 7‐azanorbornane scaffold through click chemistry, we prepared a small‐sized library. Screening for some receptors furnished several bioactive agents with high hit rates.
- Is Part Of:
- ChemMedChem. Volume 14:Number 21(2019)
- Journal:
- ChemMedChem
- Issue:
- Volume 14:Number 21(2019)
- Issue Display:
- Volume 14, Issue 21 (2019)
- Year:
- 2019
- Volume:
- 14
- Issue:
- 21
- Issue Sort Value:
- 2019-0014-0021-0000
- Page Start:
- 1840
- Page End:
- 1848
- Publication Date:
- 2019-09-20
- Subjects:
- 7-azanorbornane -- drug design -- lead identification -- medicinal chemistry -- sp3 carbon atoms
Pharmaceutical chemistry -- Periodicals
615.19005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1860-7187 ↗
http://www3.interscience.wiley.com/cgi-bin/jhome/110485305 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/cmdc.201900398 ↗
- Languages:
- English
- ISSNs:
- 1860-7179
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3172.254000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 20662.xml